EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients

Jean-Pierre Bellier iD, Yuqi Cai iD, Sarah M Alam iD, Thorsten Wiederhold, Arica Aiello, Jonathan S Vogelgsang iD, Sabina Berretta iD, Jasmeer P Chhatwal iD, Dennis J Selkoe iD, Lei Liu iD

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Jean-Pierre Bellier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION A wide array of post‐translational modifications of the tau protein occurs in Alzheimer's disease (AD) and they are critical to pathogenesis and biomarker development. Several promising tau markers, pT181, pT217, and pT231, rely on increased phosphorylation within a common molecular motif threonine‐proline‐proline (TPP). METHODS We validated new and existing antibodies against pT217, pT231, pT175, and pT181, then combined immunohistochemistry (IHC) and immunoassays (ELISA) to broadly examine the phosphorylation of the tau TPP motif in AD brains. RESULTS The tau burden, as examined by IHC and ELISA, correlates to Braak stages across all TPP sites. Moreover, we observed regional variability across four TPP motif phosphorylation sites in multiple brains of sporadic AD patients. DISCUSSION We conclude that there is an elevation of TPP tau phosphorylation in AD brains as disease advances. The regional variability of pTPP tau suggests that examining different phosphorylation sites is essential for a comprehensive assessment of tau pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumanstau ProteinsPhosphorylationThreonineBrainProline

Stichwörter der Autor:innen

Alzheimer's diseasebrainphosphorylationtau protein

Substanzen

tau ProteinsThreonineProline

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Cell Signaling Technology, Inc., Danvers, Massachusetts, USA.
  • McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
  • Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Jean-Pierre Bellier, Yuqi Cai, Sarah M Alam, Jonathan S Vogelgsang, Sabina Berretta, Jasmeer P Chhatwal, Dennis J Selkoe, Lei Liu

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bellier, J. P., Cai, Y., Alam, S. M., Wiederhold, T., Aiello, A., Vogelgsang, J. S., Berretta, S., Chhatwal, J. P., Selkoe, D. J., & Liu, L. (2024). Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13557

Vancouver

Bellier JP, Cai Y, Alam SM, Wiederhold T, Aiello A, Vogelgsang JS, et al. Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13557

BibTeX
@article{Bellier2024,
  author = {Bellier, Jean-Pierre and Cai, Yuqi and Alam, Sarah M and Wiederhold, Thorsten and Aiello, Arica and Vogelgsang, Jonathan S and Berretta, Sabina and Chhatwal, Jasmeer P and Selkoe, Dennis J and Liu, Lei},
  title = {Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13557}
}
Kostenlos starten →